Skip to content
OpenCapital
Get started

Utah Medical Products UTMD Increase (Decrease) in Other Receivables

Increase (Decrease) in Other Receivables at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
——

Other financials

Income statement

See full
Revenue$8.7M-10.2%
Gross profit$5.3M-4.6%
Operating income$2.6M-18.6%
Net income$2.6M-14.4%
EPS (diluted)$0.82-10.9%

Balance sheet

See full
Cash & equivalents$87.4M+4.9%
Total debt$210.0K—
Total equity$120.4M+2.8%
Total assets$124.4M+1.5%

Cash flow

See full
Operating cash flow$3.1M-30.4%
CapEx$130.0K-29.3%
Free cash flow$3.0M-30.4%

Valuation

See full
Market cap$219.63M+26.4%
Enterprise value$132.44M+42.5%
P/E20.3×+6.4×
P/S5.9×+1.4×

Profitability

See full
Gross margin57.9%-0.4pp
Operating margin28.8%-3.9pp
Net margin28.9%-4.1pp
FCF margin34.7%0.0pp

Returns & leverage

See full
Return on equity9.1%-1.4pp
Debt / equity0×—
Current ratio28.6×+6.3×

Where this comes from

Reported directly by Utah Medical Products in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherReceivables.

The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Utah Medical Products's increase (decrease) in other receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Utah Medical Products's increase (decrease) in other receivables?
Utah Medical Products (UTMD) reported increase (decrease) in other receivables of $1.25K in Q4 2025.
How has Utah Medical Products's increase (decrease) in other receivables changed year-over-year?
Utah Medical Products's increase (decrease) in other receivables increased by 109.3% year-over-year, from -$13.5K to $1.25K.
What is the long-term trend for Utah Medical Products's increase (decrease) in other receivables?
Over 4 years (2021 to 2025), Utah Medical Products's increase (decrease) in other receivables has grown at a -41.3% compound annual growth rate (CAGR), from $42K to $5K.